Trials / Completed
CompletedNCT01054716
Evaluation of a Noninvasive Fetal RHD Genotyping Test
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Sequenom, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study will collect whole blood samples from pregnant subjects who are RhD negative by serology to develop an assay for RHD determination of the fetus.
Conditions
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2010-01-22
- Last updated
- 2011-09-05
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01054716. Inclusion in this directory is not an endorsement.